| scholarly article | Q13442814 |
| P50 | author | Ellen Puré | Q88789171 |
| P2093 | author name string | James Monslow | |
| Leslie Todd | |||
| Richard K Assoian | |||
| John E Chojnowski | |||
| Priya K Govindaraju | |||
| P2860 | cites work | Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts | Q22010913 |
| Structural and kinetic analysis of the substrate specificity of human fibroblast activation protein alpha | Q28243456 | ||
| The adhesion receptor CD44 promotes atherosclerosis by mediating inflammatory cell recruitment and vascular cell activation | Q28360727 | ||
| A major role for VCAM-1, but not ICAM-1, in early atherosclerosis | Q28365883 | ||
| Heart disease and stroke statistics--2011 update: a report from the American Heart Association | Q29547236 | ||
| Vascular Smooth Muscle Cells in Atherosclerosis | Q30277316 | ||
| Smooth muscle cell phenotypic switching in atherosclerosis | Q30418243 | ||
| Human IL-8 regulates smooth muscle cell VCAM-1 expression in response to endothelial cells exposed to atheroprone flow | Q30438030 | ||
| Disruption of SEMA4D ameliorates platelet hypersensitivity in dyslipidemia and confers protection against the development of atherosclerosis | Q30494712 | ||
| Fibroblast activation protein peptide substrates identified from human collagen I derived gelatin cleavage sites | Q33311561 | ||
| Targeting fibroblast activation protein in tumor stroma with chimeric antigen receptor T cells can inhibit tumor growth and augment host immunity without severe toxicity | Q33555573 | ||
| Tumoral immune suppression by macrophages expressing fibroblast activation protein-α and heme oxygenase-1. | Q33557006 | ||
| Arterial stiffness and cardiovascular events: the Framingham Heart Study | Q33720064 | ||
| Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers | Q33801657 | ||
| Targeted disruption of mouse fibroblast activation protein | Q33961797 | ||
| Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. | Q34307809 | ||
| Macrophages in atherosclerosis: a dynamic balance. | Q34368005 | ||
| Lifestyle effects on hematopoiesis and atherosclerosis | Q34668164 | ||
| Fibroblast activation protein expression by stromal cells and tumor-associated macrophages in human breast cancer. | Q34816275 | ||
| Vascular stiffness and increased pulse pressure in the aging cardiovascular system | Q35159119 | ||
| Fibroblast activation protein is induced by inflammation and degrades type I collagen in thin-cap fibroatheromata | Q35492880 | ||
| Inhibition of indoleamine 2,3-dioxygenase promotes vascular inflammation and increases atherosclerosis in Apoe-/- mice. | Q35573469 | ||
| Fibroblast activation protein is expressed by rheumatoid myofibroblast-like synoviocytes | Q35630052 | ||
| Tumor-Promoting Desmoplasia Is Disrupted by Depleting FAP-Expressing Stromal Cells. | Q35862799 | ||
| Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture | Q35993294 | ||
| Heme oxygenase-1, oxidation, inflammation, and atherosclerosis | Q36103851 | ||
| Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates | Q36305029 | ||
| Sexual dimorphism in rodent models of hypertension and atherosclerosis | Q36346910 | ||
| Fibroblast Activation Protein (FAP) Accelerates Collagen Degradation and Clearance from Lungs in Mice | Q36778823 | ||
| Metalloelastase is required for macrophage-mediated proteolysis and matrix invasion in mice | Q36799271 | ||
| Arterial stiffness as a risk factor for coronary atherosclerosis | Q36945227 | ||
| Age-related intimal stiffening enhances endothelial permeability and leukocyte transmigration | Q36957712 | ||
| Interfering with extracellular matrix degradation to blunt inflammation | Q37112292 | ||
| Assessment of arterial stiffness, a translational medicine biomarker system for evaluation of vascular risk. | Q37266665 | ||
| Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice | Q37452281 | ||
| Cardiovascular risk in menopausal women and prevalent related co-morbid conditions: facing the post-Women's Health Initiative era. | Q37584800 | ||
| Cyclooxygenase-2 in endothelial and vascular smooth muscle cells restrains atherogenesis in hyperlipidemic mice | Q37735500 | ||
| TGFβ signaling and cardiovascular diseases | Q37976673 | ||
| Estrogens and atherosclerosis: insights from animal models and cell systems | Q37987111 | ||
| Fibroblast activation protein in remodeling tissues | Q38029752 | ||
| Pathophysiology of atherosclerosis plaque progression | Q38094421 | ||
| Use of Mouse Models in Atherosclerosis Research | Q38601635 | ||
| Fibroblast activation protein alpha is expressed by transformed and stromal cells and is associated with mesenchymal features in glioblastoma. | Q38753773 | ||
| Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha | Q39635625 | ||
| Fibroblast activation protein: a serine protease expressed at the remodeling interface in idiopathic pulmonary fibrosis | Q40334332 | ||
| FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3-CCL2 Signaling | Q40740027 | ||
| Cardiovascular protection by ApoE and ApoE-HDL linked to suppression of ECM gene expression and arterial stiffening | Q41929558 | ||
| CD44 expressed on both bone marrow-derived and non-bone marrow-derived cells promotes atherogenesis in ApoE-deficient mice | Q46638079 | ||
| Peptide substrate profiling defines fibroblast activation protein as an endopeptidase of strict Gly(2)-Pro(1)-cleaving specificity | Q46946377 | ||
| Extracellular matrix directs phenotypic heterogeneity of activated fibroblasts | Q47285215 | ||
| Prolyl hydroxylase 3 overexpression accelerates the progression of atherosclerosis in ApoE-/- mice. | Q53142780 | ||
| Fibroblast activation protein alpha expression identifies activated fibroblasts after myocardial infarction. | Q53363037 | ||
| Evaluation of the radiolabeled boronic acid-based FAP inhibitor MIP-1232 for atherosclerotic plaque imaging. | Q54175877 | ||
| Fibroblast activation protein: A cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodelling interface in human cirrhosis | Q60617867 | ||
| Cardiovascular protection in females linked to estrogen-dependent inhibition of arterial stiffening and macrophage MMP12 | Q64235518 | ||
| Suppression of atherosclerotic plaque progression and instability by tissue inhibitor of metalloproteinase-2: involvement of macrophage migration and apoptosis | Q64377816 | ||
| Estrogen in vascular smooth muscle cells: A friend or a foe? | Q64921426 | ||
| Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population | Q70009095 | ||
| Regulation and heteromeric structure of the fibroblast activation protein in normal and transformed cells of mesenchymal and neuroectodermal origin | Q70463981 | ||
| Expression of the adhesion molecules ICAM, VCAM, and ELAM in the arteriosclerotic plaque | Q71467460 | ||
| Targeting fibroblast activation protein in cancer - Prospects and caveats | Q88717620 | ||
| The role of smooth muscle cells in plaque stability: Therapeutic targeting potential | Q93119377 | ||
| P921 | main subject | sexual dimorphism | Q181497 |
| P577 | publication date | 2020-02-19 | |
| P1433 | published in | The American Journal of Pathology | Q4744259 |
| P1476 | title | Fibroblast Activation Protein Regulates Lesion Burden and the Fibroinflammatory Response in Apoe-Deficient Mice in a Sexually Dimorphic Manner |
Search more.